Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain Cancer
Open accessThe DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Abstract
Nanotheranostics have demonstrated the development of advanced platforms that can diagnose brain cancer at early stages, initiate first-line therapy, monitor it, and if needed, rapidly start subsequent treatments. In brain nanotheranostics, therapeutic as well as diagnostic entities are loaded in a single nanoplatform, which can be further developed as a clinical formulation for targeting various modes of brain cancer. In the present review, we concerned about theranostic nanosystems established till now in the research field. These include gold nanoparticles, carbon nanotubes, magnetic nanoparticles, mesoporous silica nanoparticles, quantum dots, polymeric nanoparticles, upconversion nanoparticles, polymeric micelles, solid lipid nanoparticles and dendrimers for the advanced detection and treatment of brain cancer with advanced features. Also, we included the role of three-dimensional models of the BBB and cancer stem cell concept for the advanced characterization of nanotheranostic systems for the unification of diagnosis and treatment of brain cancer. In future, brain nanotheranostics will be able to provide personalized treatment which can make brain cancer even remediable or at least treatable at the primary stages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Applications of magnetic nanoparticles in biomedicine
Pankhurst, Q. A., Connolly, J., Jones, S. K., & Dobson, J. (2003) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/36/13/201 · Cited by 5,881 · cited 3×
“Owing to the magnetic response, iron oxide core facilitates the magnetic targeted delivery [84, 85].”
BackgroundAstrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595 · cited 1×
“BBB is an active functional element composed of brain endothelial cells, astrocytes and pericytes as well [64].”
BackgroundUpconversion and Anti-Stokes Processes with f and d Ions in Solids
Auzel, F. (2004) · Chemical Reviews · doi:10.1021/cr020357g · Cited by 5,098 · cited 1×
“In particular, lanthanide-based UCNPs are reported as highly safer materials for nanotheranostic purposes and are quickly eliminated by hepatobiliary and renal excretion routes [106].”
BackgroundPLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806 · cited 1×
“These PLGA nanoparticles were transported by pinocytosis and also by clathrin-mediated endocytosis [114].”
BackgroundNanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901 · cited 1×
“Second, nanocarriers are competent enough to improve the pharmacokinetics and to enhance the biodistribution of existing therapeutic moieties to the target tissues, so that can improve efficiency [27].”
BackgroundOstrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou223 · Cited by 1,718
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422 · cited 4×
“The loading of a therapeutic molecule is accomplished by electrostatic interaction or covalent conjugation [17, 61, 62].”
BackgroundInfluentialImaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248 · cited 1×
“PET can more efficiently characterize brain tumors by investigating metabolic processes such as receptor binding, DNA synthesis or enzyme activity, oxygen metabolism and blood flow [54-57].”
BackgroundThe unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy
Doane, T. L., & Burda, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15260f · Cited by 1,098
Cited by
Recent advances and prospects of carbon dots in phototherapy
Li, B., Zhao, S., Huang, L., Wang, Q., Xiao, J., & Lan, M. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.127245 · Cited by 214
Recent advances and prospects of carbon dots in cancer nanotheranostics
Jia, Q., Zhao, Z., Liang, K., Nan, F., Li, Y., Wang, J., Ge, J., & Wang, P. (2020) · Materials Chemistry Frontiers · doi:10.1039/c9qm00667b · Cited by 161
Nicolson, F., Andreiuk, B., Andreou, C., Hsu, H.-T., Rudder, S., & Kircher, M. F. (2019) · Theranostics · doi:10.7150/thno.36321 · Cited by 152
“While theranostic approaches to improve diagnosis and cure rates of various cancer types is a very active area of research with multiple approaches being tested [4-18], complete tumor resection, which can only be achieved via complete tumor visualization, is deemed the most important factor for the outcome of GBM pati…”
BackgroundA Review on Theranostics: An Approach to Targeted Diagnosis and Therapy
Shrivastava, S., Jain, S., Kumar, D., Soni, S. L., & Sharma, M. (2019) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v7i2.463 · Cited by 53
“Second, nanocarriers are competent enough to improve the pharmacokinetics and to enhance the biodistribution of existing therapeutic moieties to the target tissues, so that can improve efficiency.(8)”
Background
Metadata
- Authors
- Sonali, Viswanadh, M. K., Singh, R. P., Agrawal, P., Mehata, A. K., Pawde, D. M., Narendra, Sonkar, R., & Muthu, M. S.
- Venue
- Nanotheranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2018
- Volume
- 2
- Issue
- 1
- Pages
- 70-86
- ISSN
- 2206-7418 (ISSN-L)
- OpenAlex
- W2771352686
- Cited by
- 169
- References
- 132
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain Cancer. https://app.cochat.ai/papers/10.7150/ntno.21638
- The paper
- Sonali, Viswanadh, M. K., Singh, R. P., Agrawal, P., Mehata, A. K., Pawde, D. M., Narendra, Sonkar, R., & Muthu, M. S. (2018). Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain Cancer. Nanotheranostics. https://doi.org/10.7150/ntno.21638
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.